Anthony Gerber, MD, PhD, has been selected to serve as the division chief for pulmonary, critical care, and sleep medicine in the University of Kentucky College of Medicine Department of Internal Medicine, effective Nov. 4, 2025.
Dr. Gerber currently serves as professor and director of pulmonary research in the division of pulmonary, critical care, and sleep medicine in the department of medicine at National Jewish Health (NJH). He is also a professor of immunology and genomic medicine and is the grant program director.
As an active clinician at NJH, he supports the Asthma Treatment Program (Adult) and the Chronic Obstructive Pulmonary Disease (COPD) Program. His clinical specialty focus areas are asthma, chronic cough, and COPD. His research areas are asthma and cellular and molecular biology.
Dr. Gerber has nearly a decade of experience working on air quality as a member of the Colorado Air Quality Control Commission. He has significant expertise regarding the clinical, regulatory, and public health challenges associated with the impacts of air pollution, including navigating the complex trade-offs between the positive health impacts of regulations to control emissions and the negative impacts on industry.
As a consultant and entrepreneur, Dr. Gerber served as the lead medical advisor on three successful 510K applications and led the development of COPD and asthma “smart app” triage tools based on machine learning methodology. He also founded Psammiad Therapeutics, which is creating improved anti-inflammatories to treat COPD exacerbations.
Dr. Gerber has participated in a variety of NIH grant and program site reviews, and he provides mentorship for trainees and junior faculty. He has received multiple honors including the Ruben Cherniack Distinguished Service Award from National Jewish Health. He serves on the editorial boards for the Journal of Biological Chemistry, Chest, and the American Journal of Respiratory Cell and Molecular Biology.
Dr. Gerber earned his bachelor’s degree in mathematics from the Massachusetts Institute of Technology. He completed a doctorate program in pathology and medical school at the University of Washington, prior to residency and fellowships in pulmonary and critical care at the University of California, San Francisco, where he served on the faculty from 2006-09.